Literature DB >> 32000819

Multisession radiosurgery for intracranial meningioma treatment: study protocol of a single arm, monocenter, prospective trial.

V Pinzi1, M Marchetti2, E De Martin3, V Cuccarini4, I Tramacere5, F Ghielmetti3, M L Fumagalli3, C Iezzoni2, L Fariselli2.   

Abstract

BACKGROUND: Single session radiosurgery represents a widely accepted treatment for intracranial meningiomas. However, this approach could involve a high risk of treatment-related complications when applied to large volume lesions. In these cases and for those not suitable for surgical resection, radiosurgery in multisession setting could represents a viable option. The literature results are reassuring in terms of correlated adverse events as well as in terms of tumor control. However, no prospective long-term results are available. In this scenario, we design a prospective monocentric phase II study, in order to verify the safety of a multisession radiosurgery schedule delivering 25 Gy in 5 daily fractions. <br> METHODS: Patients diagnosed with large and/or near to critical structures, intracranial meningiomas have been treated by means of multisession radiosurgery in both exclusive and postoperative settings. The primary study aim is safety that has been being prospectively scored based on international scales, including NCI Common Toxicity criteria, version 4.03, Barrow Neurological Institute pain intensity score, Barrow Neurological Institute facial numbness score and House-Brackmann Facial Nerve Grading System for qualitative analysis. Secondary aim is treatment efficacy in terms of local control that has been being assessed on volumetric analysis. DISCUSSION: This is the first prospective phase II trial on multisession radiosurgery for large and/or near to critical structures intracranial meningiomas. If positive results will be found, this study could represent the starting point for a phase III trial exploring the role of multisession radiosurgery in the exclusive and postoperative radiation therapy treatment of intracranial meningiomas. TRIAL REGISTRATION: Trial registration: clinicaltrials.gov platform (Multisession Radiosurgery in Large Meningiomas -MuRaLM- identifier NCT02974127). Registered: November 28, 2016. Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT02974127?term=radiosurgery&cond=Intracranial+Meningioma&draw=2&rank=1.

Entities:  

Keywords:  Cavernous sinus meningioma; Fractionated radiosurgery; Hypofractionated stereotactic radiotherapy; Intracranial meningioma; Large meningioma; Multisession radiosurgery; Neurological function preservation; Optic pathway meningioma; Radiosurgery

Year:  2020        PMID: 32000819     DOI: 10.1186/s13014-020-1478-7

Source DB:  PubMed          Journal:  Radiat Oncol        ISSN: 1748-717X            Impact factor:   3.481


  3 in total

1.  Multisession radiosurgery for grade 2 (WHO), high risk meningiomas. A phase II clinical trial.

Authors:  Marcello Marchetti; Valentina Pinzi; Cecilia Iezzoni; Sara Morlino; Irene Tramacere; Elena De Martin; Irene Cane; Laura Fariselli
Journal:  J Neurooncol       Date:  2022-04-04       Impact factor: 4.506

2.  Trends in the use of radiation for meningioma across the United States.

Authors:  Hirsch Matani; Stephen Abel; Alexander Yu; Stephen M Karlovits; Rodney E Wegner
Journal:  Radiat Oncol J       Date:  2022-03-15

3.  Strategies for intraoperative management of the trigeminal nerve and long-term follow-up outcomes in patients with trigeminal neuralgia secondary to an intracranial epidermoid cyst.

Authors:  Zhenyu Zhang; Wenhua Wang; Feng Yu; Sze Chai Kwok; Yuhai Wang; Jia Yin
Journal:  Front Surg       Date:  2022-07-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.